title: Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
authors.affiliation: Department of Medicine, Rheumatology, Benjamin Franklin Hospital, Free University Berlin, and German Rheumatology Research Centre, Berlin, Germany. jbraun@zedat.fu-berlin.de
authors.forename: J
authors.initials: J
authors.lastname: Braun
authors.forename: J
authors.initials: J
authors.lastname: Xiang
authors.forename: J
authors.initials: J
authors.lastname: Brandt
authors.forename: H
authors.initials: H
authors.lastname: Maetzel
authors.forename: H
authors.initials: H
authors.lastname: Haibel
authors.forename: P
authors.initials: P
authors.lastname: Wu
authors.forename: S
authors.initials: S
authors.lastname: Kohler
authors.forename: M
authors.initials: M
authors.lastname: Rudwaleit
authors.forename: S
authors.initials: S
authors.lastname: Siegert
authors.forename: A
authors.initials: A
authors.lastname: Radbruch
authors.forename: A
authors.initials: A
authors.lastname: Thiel
authors.forename: J
authors.initials: J
authors.lastname: Sieper
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D013166:Spondylitis / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha